These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)]. Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083 [No Abstract] [Full Text] [Related]
8. Synthesis of potential antineoplastic agents. 35. Phosphorus-containing structural analogs of myleran. Struck RF J Med Chem; 1966 Mar; 9(2):231-4. PubMed ID: 5911803 [No Abstract] [Full Text] [Related]
9. [Effect of HB 419 on exogenous and endogenous insulin in dogs and rabbits]. Pfaff W; Schröder HG Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1488-91. PubMed ID: 5394472 [No Abstract] [Full Text] [Related]
10. A NEW HYPOGLYCEMIC COMPOUND, 1-CYCLOHEXYL-3-(5-INDANYLSULFONYL) UREA. LERNER LJ; BIANCHI A; BORMAN A Metabolism; 1965 May; 14():578-82. PubMed ID: 14289483 [No Abstract] [Full Text] [Related]
11. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)]. García-Rafanell J; Morell-Mestre J Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448 [No Abstract] [Full Text] [Related]
12. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)]. Loubatières A; Ribes G; Mariani MM; Alric R Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420 [No Abstract] [Full Text] [Related]
13. Synthesis of isocyanates by fragmentation of sulfonylureas. Ulrich H; Sayigh AA Angew Chem Int Ed Engl; 1966 Aug; 5(8):724-5. PubMed ID: 4962478 [No Abstract] [Full Text] [Related]
14. [Comparative studies between HB 419 (glibenclamide) and tolbutamide on their effect on insulin liberation in isolated islands of rat pancreas in vitro]. Weinges KF; Biro G; Kettl H; Mitzuno M Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1467-9. PubMed ID: 4899089 [No Abstract] [Full Text] [Related]
15. Cis-1-[(2-piperidinocyclohexyl)carbonyl]-piperidine and related compounds. Oral hypoglycemic agents. Rynbrandt RH; Schmidt FL J Med Chem; 1971 Jan; 14(1):54-6. PubMed ID: 5539748 [No Abstract] [Full Text] [Related]
16. [Effect of blood sugar decreasing sulfonylureas on the in vitro metabolism of glucose and amino acids in the beta-cells of the pancreas in mice]. Hellerström C; Westman S; Stork H; Schmidt FH Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1464-7. PubMed ID: 4899088 [No Abstract] [Full Text] [Related]
17. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide). Loubatiéres A; Mariani MM; Ribes G; Alric R Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675 [No Abstract] [Full Text] [Related]